Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Stroma Mediated Drug Resistance in Pancreatic Ductal Adenocarcinoma
EF 2015-16
Résumé
Pancreatic ductal adenocarcinoma (PDAC) accounts for more than 90% of pancreatic cancers and is amongst the most lethal malignancies. Recently approved therapies for metastatic PDAC have not yet achieved long-term survival due to tumor chemotherapy resistance. A hallmark of PDAC is the extensive connective tissue, known as the stroma, surrounding cancer cells. Our group and others have shown that tumor stroma can modulate drug responses and can confer resistance to breast cancers therapies. Therefore, it is crucial to understand the role of pancreatic cancer microenvironment in mediating drug resistance and to formulate effective treatment strategies to overcome this challenge. The overall goal of this project is to mechanistically understand the influence of stroma on PDAC drug resistance and identify targets that can be exploited therapeutically. To do so, I will firstly identify stroma subtypes that promote chemo-resistance of PDAC. Secondly, I will identify druggable targets to overcome this stroma-mediated chemo-resistance. My research project will allow me to identify stroma-associated factors which promote drug resistance in PDAC that can be targeted by FDA approved drugs. Given that the extensive stromal involvement is a key hallmark of PDAC such novel therapeutic strategies, targeting the microenvironment, may be a more effective means to treat PDAC patients.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
350081
Name
Ferwati Sara
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Stroma Mediated Drug Resistance in Pancreatic Ductal Adenocarcinoma
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
3d Cell Culture Models; Cancer; Cancer-Associated Fibroblasts; Drug Resistance; Functional Genomics; Pancreatic Ductal Adenocarcinoma; Tumor Microenvironment
Abstract
Pancreatic ductal adenocarcinoma (PDAC) accounts for more than 90% of pancreatic cancers and is amongst the most lethal malignancies. Recently approved therapies for metastatic PDAC have not yet achieved long-term survival due to tumor chemotherapy resistance. A hallmark of PDAC is the extensive connective tissue, known as the stroma, surrounding cancer cells. Our group and others have shown that tumor stroma can modulate drug responses and can confer resistance to breast cancers therapies. Therefore, it is crucial to understand the role of pancreatic cancer microenvironment in mediating drug resistance and to formulate effective treatment strategies to overcome this challenge. The overall goal of this project is to mechanistically understand the influence of stroma on PDAC drug resistance and identify targets that can be exploited therapeutically. To do so, I will firstly identify stroma subtypes that promote chemo-resistance of PDAC. Secondly, I will identify druggable targets to overcome this stroma-mediated chemo-resistance. My research project will allow me to identify stroma-associated factors which promote drug resistance in PDAC that can be targeted by FDA approved drugs. Given that the extensive stromal involvement is a key hallmark of PDAC such novel therapeutic strategies, targeting the microenvironment, may be a more effective means to treat PDAC patients.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ferwati, Sara
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~